Bone marrow aspirate concentrate with cancellous allograft versus iliac crest bone graft in the treatment of long bone nonunions

The purpose of this study was to compare bone marrow aspirate concentrate (BMAC) with cancellous allograft to iliac crest bone graft (ICBG) in the treatment of long bone nonunions. Retrospective cohort study. A single level I trauma center. 26 patients with long bone diaphyseal or metaphyseal nonuni...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:OTA international : the open access journal of orthopaedic trauma 2019-03, Vol.2 (1), p.e012-e012
Hauptverfasser: Lin, Kenneth, VandenBerg, James, Putnam, Sara M, Parks, Christopher D, Spraggs-Hughes, Amanda, McAndrew, Christopher M, Ricci, William M, Gardner, Michael J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The purpose of this study was to compare bone marrow aspirate concentrate (BMAC) with cancellous allograft to iliac crest bone graft (ICBG) in the treatment of long bone nonunions. Retrospective cohort study. A single level I trauma center. 26 patients with long bone diaphyseal or metaphyseal nonunions with defects >2 mm and treated with open repair and BMAC, compared to 25 patients with long bone diaphyseal or metaphyseal nonunions with defects >2 mm and treated with open repair and ICBG. Open repair of long bone nonunion using either autologous ICBG or BMAC with cancellous allograft. Nonunion healing, radiographically measured by the modified Radiographic Union Score for Tibia (mRUST) score. Secondary outcomes included risk factors associated with failed repair. The union rates for the BMAC and ICBG cohorts were 75% and 78%, respectively ( .8). Infection was the only risk factor of statistical significance for failure. In this study, we found no significant difference in union rate for long bone nonunions treated with ICBG or BMAC with allograft. BMAC and allograft led to 75% successful healing in this series. Given the heterogeneity of the control group and loss to follow-up, further prospective investigation should be conducted to more rigorously compare BMAC to ICBG for nonunion treatment. III, retrospective cohort.
ISSN:2574-2167
2574-2167
DOI:10.1097/OI9.0000000000000012